Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified oligonucleotides for use in treatment of tauopathies

Modified oligonucleotides for use in treatment of tauopathies

US Patent 11453881 · Granted Sep 27, 2022

Estimated economic value: $272,001,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GalNAc derivatives2025
GalNAc derivatives2025
GalNAc derivatives2025
Modified short interfering nucleic acid (siNA) molecules and uses thereof2025
Modified short interfering nucleic acid (siNA) molecules and uses thereof2025
Modified nucleoside phosphoramidites2025
Modified nucleoside phosphoramidites2025
Modified nucleoside phosphoramidites2025
Guanine analogs as telomerase substrates and telomere length affectors2025
Anti-viral compounds2025
Substituted nucleosides, nucleotides and analogs thereof2024
Modified short interfering nucleic acid (siNA) molecules and uses thereof2024